Precigen, Inc.
NASDAQ:PGEN · NASDAQ Global Select
-$0.10 today
Vol 4.20M · Avg 4.72M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+225.68%
Period High
$5.21
Period Low
$1.42
Latest
$4.82
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
$3.35B
Relay Therapeutics, Inc.
NASDAQ:RLAY
$2.79B
Enliven Therapeutics, Inc.
NASDAQ:ELVN
$2.74B
Immatics N.V.
NASDAQ:IMTX
$1.30B
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
$1.28B
Tourmaline Bio, Inc.
TRML
$1.23B
Nektar Therapeutics
NASDAQ:NKTR
$1.17B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.17B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$881.97M
What is the latest PGEN filing?
The latest filing shown is 4 dated Jun 1, 2026.
How many recent filings does PGEN have?
Intrinsic Alpha currently shows 20 recent filings for PGEN.
Explore More
Continue the stock analysis
Jump to another research area for this company.